Navigation Links
NBTY Reports Fourth Quarter and Fiscal Year Results
Date:11/11/2008

RONKONKOMA, N.Y., Nov. 11 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (http://www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced results for the fiscal fourth quarter and fiscal year ended September 30, 2008.

For the fiscal fourth quarter ended September 30, 2008, net sales were $602 million compared to net sales of $496 million for the fiscal fourth quarter ended September 30, 2007, an increase of $105 million, or 21%. Net income for the fiscal fourth quarter ended September 30, 2008 was $18 million, or $0.28 per diluted share, compared to net income of $48 million, or $0.70 per diluted share, for the fiscal fourth quarter ended September 30, 2007.

The decline in net income primarily reflects lower gross profit margin, Leiner acquisition-related integration costs, weak sales in the European Retail operation, investment in information technology infrastructure and increased freight costs. Overall gross profit margins for the fiscal fourth quarter of 2008 decreased to 44% from 52% for the fiscal fourth quarter of 2007. This gross margin compression was mainly due to higher raw material and other manufacturing costs which were not offset by higher prices charged to customers, increased promotional sales in the Wholesale/US Nutrition and Direct Response/E-Commerce operations and lower margins on Leiner private label products. NBTY acquired Leiner Health Products on July 14, 2008 and incurred acquisition-related integration costs of $12 million, consisting of severance costs, increased payroll and certain adjustments to acquired inventory. These adjustments were required under purchase accounting rules to record this inventory at fair value. This results in temporary compression in gross profit when this inventory is sold. The integration plan will result in the elimination of 250 Leiner associates. NBTY expects integration costs to continue over
'/>"/>

SOURCE NBTY, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. IPC The Hospitalist Company Reports Record Third Quarter 2008 Results
2. Consumer Reports Survey: Nearly Half of Adults Wont Get Flu Vaccine, Citing Poor Excuses Like I Dont Get Sick
3. Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
4. MIB Life Index Reports North American Life Insurance Activity Off 1.8% in October
5. General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results
6. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
7. Immtech Reports Fiscal Second Quarter 2009 Results
8. Synthetech Reports Second Quarter Fiscal 2009 Results
9. Omega Protein Reports 17 Cents Per Share Third Quarter Profit
10. Mesa Labs Reports Higher Quarterly Sales and Earnings
11. Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliants Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Logic today announced MathMagic Personal Edition 4...tor. With a focus on the equation quality and ease...e equation editor for mathematical equations and s...y standard mathematical expressions including LaTe...Docs and Zoho Writer, and other enhanced features....
(Date:12/4/2009)...ibOx, a leading developer of novel and effective c...d forces with MolPort, an innovator in rare chemic...mical trading platform and builds database of comm...database and its updates to computational chemists...tual screening procedures. Once they identify suit...
(Date:12/4/2009)...h American Seminars Inc. is now accepting medical ...ucation courses at their medical facility in 2010....eration and capabilities to the medical community ...heir physical therapy and occupational therapy tea...250 live training events. , ...
(Date:12/4/2009)...lliSoft Group offers their new IntelliChoice upgra...ialing software, IntelliSoft Group is the only ven...oyment option. ,SaaS is an excellent option for th...ints, yet are in need of medical credentialing sof... 4, 2009 -- ISG Group, LLC, doing business as Inte...
(Date:12/4/2009)...tar fasciitis heel pain affects over two million p...rapy has been cited by the American Academy of Ort... In response to these findings, Orthotics And Bey...rapy systems for plantar fasciitis treatment as a ... therapies. , (PRWEB) Dec...
Breaking Medicine News(10 mins):Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 2Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 3Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 4Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:IntelliSoft Group Focuses on Protecting Customer Investment in Medical Credentialing Systems -- Budget Constraints and Forced Upgrades in Medical Credentialing Automation 2Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2
...aching Offers Relief to Families Nationwide, SHOR...,life coach and certified parent coach, Tammy Gold...d children at a New York City mental health,clinic...ir upbringing were the real issues. The demands an...
...ney General on physician evaluations will have,nat...atement is,attributable to Nancy H. Nielsen, M.D.,...al Association (AMA) welcomes today,s announcement...king programs. Aetna,s decision to join CIGNA in a...
... iFire Technology Corp., CALGARY, Nov. 13 /PRNews...d today that for the third quarter ended September... or 18 cents per share, on revenues of,$7.8 millio...uarter of 2007, the Company recorded reorganizatio...
...plications for humans, researchers say , TUESDAY,...ydrate diet slowed prostate tumor growth, possibly...sulin production, U.S. researchers say. , "This st...mplications for prostate cancer therapy through so...
...en people with diabetes are walking around in the ...foot problems that could lead to amputation, accor...e International Journal of Clinical Practice. , ...ys that ulceration can have serious implications f...
...3, 2007 For the millions of Americans whose nativ... road block to quality healthcare, according to a ...hers in the Center for Health Policy Research in t...cal errors and lower patient satisfaction. , In...
Other Medicine News:Health News:New Practice Brings Sanity and Support to Parents 2Health News:AMA Commends Aetna for Quality First Commitment 2Health News:Westaim announces 2007 third quarter results 2Health News:Westaim announces 2007 third quarter results 3Health News:Westaim announces 2007 third quarter results 4Health News:Low-Carb Diet May Slow Prostate Tumor Growth 2Health News:63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes 2Health News:Language barriers adversely impact health-care quality 2
(Date:12/3/2009)...Pa., Dec. 3 Radiology imaging lead...d integration capabilities at the November 2009 Ra... Connect.PACS(TM) product, enabling the first rad...e latest release in the company,s newly branded C... http://www.newscom.com/cgi-bin/prnh/20091203/NE...
(Date:12/3/2009)... In response to the incr...echnologies in the evolving healthcare delivery sy...r Health Informatics (DCHI) to provide a campus fo...nnovative interdisciplinary approach to education ...nurses and healthcare administrators with an exper...
(Date:12/3/2009)... Apnex Medical, Inc., a private me...ted a second round of private equity financing tot...ete a clinical study and develop a second generati...ned to treat obstructive sleep apnea (OSA). ,, ...iates, New Enterprise Associates (NEA), Polaris Ve...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 1InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 2InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1
...s Corporation (Nasdaq: DVAX ) today reported that...weed allergy therapy, to subjects as,part of an en...d to enroll,a total of 300 subjects. Subjects are ...gy and a positive skin test. Exposure to ragweed a...se individuals with confirmed,ragweed allergic dis...
...nsistently Positive Clinical ...ta presented today from,Abbott,s SPIRIT III U.S. p...ive, statistically significant clinical results fo...nt System at one year, including continued,clinica...E) and continued,non- inferior rates of target ves...
Other Medicine Technology:Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5
House Teflon Coated Elevator
Cleft Palate Elevator
Louisville Elevator
Converse Periosteal Elevator
Medicine Products: